SBIO vs. METL
SBIO (ALPS Medical Breakthroughs ETF) and METL (Sprott Active Metals & Miners ETF) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while METL is a Commodity Producers Equities fund actively managed by Sprott. SBIO is passively managed, while METL is actively managed. At a 0.32 correlation, their price movements are largely independent. SBIO charges 0.50%/yr vs 0.89%/yr for METL.
Performance
SBIO vs. METL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a -1.72% return, which is significantly lower than METL's 7.51% return.
SBIO
- 1D
- -0.36%
- 1M
- -9.33%
- YTD
- -1.72%
- 6M
- -2.48%
- 1Y
- 59.38%
- 3Y*
- 16.69%
- 5Y*
- 1.33%
- 10Y*
- 8.36%
METL
- 1D
- 0.05%
- 1M
- -9.97%
- YTD
- 7.51%
- 6M
- 15.84%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SBIO vs. METL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | -1.72% | 39.58% |
METL Sprott Active Metals & Miners ETF | 7.51% | 28.19% |
Correlation
The correlation between SBIO and METL is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 10, 2025 | 0.32 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. METL — Risk / Return Rank
SBIO
METL
SBIO vs. METL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Sprott Active Metals & Miners ETF (METL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | METL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.33 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 4.72 | — | — |
| Martin ratioReturn relative to average drawdown | 13.54 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO | METL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.02 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.25 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 1.18 | -0.96 |
Drawdowns
SBIO vs. METL - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than METL's maximum drawdown of -27.39%. Use the drawdown chart below to compare losses from any high point for SBIO and METL.
Loading charts...
Drawdown Indicators
| SBIO | METL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -27.39% | -35.67% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -17.90% | -18.48% | +0.58% |
Average DrawdownAverage peak-to-trough decline | -28.43% | -8.24% | -20.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.40% | — | — |
Volatility
SBIO vs. METL - Volatility Comparison
Loading charts...
Volatility by Period
| SBIO | METL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.87% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 22.68% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 29.62% | 44.85% | -15.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.56% | 44.85% | -11.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.18% | 44.85% | -11.67% |
SBIO vs. METL - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than METL's 0.89% expense ratio.
Dividends
SBIO vs. METL - Dividend Comparison
SBIO has not paid dividends to shareholders, while METL's dividend yield for the trailing twelve months is around 0.92%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
METL Sprott Active Metals & Miners ETF | 0.92% | 0.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO and METL have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SBIO is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.89% for METL.
METL has the higher dividend yield at 0.92%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while METL is Commodity Producers Equities. They also come from different issuers: SS&C and Sprott. Their fees differ too: 0.50% for SBIO and 0.89% for METL.
Find the right allocation for SBIO and METL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer